Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

Anaphylaxis UK welcomes launch of Natasha’s Prize 22nd June 2026

The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community.  As a charity supporting people living with serious allergies, Anaphylaxis UK warmly
[…]

Read more
NICE publishes updated anaphylaxis guidelines on assessment and referral after emergency treatment 18th June 2026

The National Institute for Health and Care Excellence (NICE) has published updated guidance on the assessment and referral of people following emergency treatment for anaphylaxis. This new guideline replaces NICE guideline CG134 (December 2011).  The update aims to improve the
[…]

Read more
Statement regarding merge of Anaphylaxis UK and Allergy UK 11th June 2026

Anaphylaxis UK and Allergy UK to merge, creating a stronger, unified voice for people living with allergy and anaphylaxis.  Anaphylaxis UK and Allergy UK today announce their intention to merge on the 1st of October, bringing together their expertise to create a more powerful, unified voice
[…]

Read more

News Type:

Food Standards Agency Survey: Improving life for people with Food Hypersensitivity 21st February 2020

The Food Standards Agency (FSA) are inviting those affected or interested in food hypersensitivity to participate in an online survey and share their experiences. Around 2% of adults and 8% of children in the UK have a food hypersensitivity. This

Read more
Latest statement on availability of EpiPen® 0.3mg and 0.15mg Adrenaline Auto-Injectors 14th February 2020

The Anaphylaxis Campaign has received the following updated statement from Mylan regarding the availability of EpiPen. This includes information for patients, prescribers, pharmacists, hospitals and schools. Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, has

Read more
Statement regarding the death of Sam Collings 13th February 2020

The Anaphylaxis Campaign is saddened to learn of the death of Sam Collings, aged 19,  who died at Bolton Hospital on the 4th August 2019. According to media reports, neither Sam or his family had suspected that Sam suffered from

Read more
First Oral Immunotherapy Drug ‘Palforzia’ gets FDA Approval 3rd February 2020

The Anaphylaxis Campaign is delighted to hear about the success of Aimmune Therapeutics, Inc. in the approval of their oral immunotherapy drug, Palforzia, by the US Food and Drug Administration (FDA). This is the first oral immunotherapy drug that has

Read more
Clinicians & Charities Call For Urgent Action to Keep Food Allergic Children Safe in School 29th January 2020

An editorial in the February edition of Clinical and Experimental Allergy (the official journal of the British Society of Allergy and Clinical Immunology) explores the current statutory guidance on the care of children with medical conditions in schools, and highlights

Read more
Positive results in peanut allergy treatment trials 27th January 2020

Biopharmaceutical company DBV Technologies has announced positive results from its Viaskin® Peanut trial into reducing the risk of allergic reaction in children aged 4 to 11. Viaskin is a patch applied directly to the surface of the skin and contains

Read more
Update from Sacla regarding pesto recall 20th January 2020

The Anaphylaxis Campaign has received and has been asked to share the following update from Sacla regarding its recent pesto recall. Update from Sacla: Customer health and safety is always our number one priority. In December, when we became aware that cashew

Read more
Statement Regarding the Inquest of Shante Turay-Thomas 13th January 2020

The Coroner has ended the inquest into the death of Shante Turay-Thomas and has delivered her narrative determination and the Prevention of Future Deaths report. The Anaphylaxis Campaign would like to extend our deepest condolences to the family of Shante,

Read more
Statement regarding the death of Ken Matthews 6th January 2020

The Anaphylaxis Campaign is saddened to learn of the death of Ken Matthews, 84,  who died at Wrexham Maelor Hospital on 2 June 2019. Consultant pathologist Dr Huyen Abdel Salam told the inquest that Mr Matthews died of an allergic

Read more